Question 1

What is COAGULATION FACTOR IX RECOMBINANT used for?

Accepted Answer

COAGULATION FACTOR IX RECOMBINANT (brand name REBINYN) is a Other indicated for 1 INDICATIONS AND USAGE REBINYN, Coagulation Factor IX (Recombinant), GlycoPEGylated.

Question 2

How does COAGULATION FACTOR IX RECOMBINANT work?

Accepted Answer

COAGULATION FACTOR IX RECOMBINANT works through the following mechanism: 12.1 Mechanism of Action Patients with hemophilia B are deficient in coagulation Factor IX, which is required for effective hemostasis. Treatment with REBINYN temporarily replaces the missing coagulation Factor IX. The Factor IX in REBINYN is conjugated to a 40-kDa polyethylene glycol molecule, which slows down its removal from the blood circulation..

Question 3

What are the most common side effects of COAGULATION FACTOR IX RECOMBINANT?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for COAGULATION FACTOR IX RECOMBINANT. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is COAGULATION FACTOR IX RECOMBINANT the same as REBINYN?

Accepted Answer

REBINYN is a brand name for COAGULATION FACTOR IX RECOMBINANT. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

COAGULATION FACTOR IX RECOMBINANT

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations